Aurinia Starts Phase 3 Trial of Voclosporin, Which Is Proving Effective Against Lupus Nephritis
Aurinia Pharmaceuticals has started a Phase 3 clinical trial of voclosporin, which eliminated an inflammatory kidney condition known as lupus nephritis in more than half of patients tested in a Phase 2b trial. The complete response rate of 49 percent of the patients in the Phase 2b trial was…